X

Thank you for sharing!

Your article was successfully shared with the contacts you provided.
Drugs and coins Any true relief for employer plans remains in the mid-to-distant future–unless pharmaceutical companies decide to proactively reduce prices to fend off reforms. (Photo: Shutterstock)

Employers hoping for quick relief to their prescription drug cost pain were disappointed by President Trump’s price-reduction speech Friday. However, the ambitious, multi-pronged attack on escalating prices–dubbed American Patients First– may at least set the stage for further debate. And that could be a positive outcome for benefits plan designers and administrators who now struggle with the unpredictability of plan costs.

Dan Cook

Dan Cook is a journalist and communications consultant based in Portland, OR. During his journalism career he has been a reporter and editor for a variety of media companies, including American Lawyer Media, BusinessWeek, Newhouse Newspapers, Knight-Ridder, Time Inc., and Reuters. He specializes in health care and insurance related coverage for BenefitsPRO.

More from this author

BenefitsPRO

Join BenefitsPRO

Don’t miss crucial news and insights you need to navigate the shifting employee benefits industry. Join BenefitsPRO.com now!

  • Unlimited access to BenefitsPRO.com - your roadmap to thriving in a disrupted environment
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com
  • Exclusive discounts on BenefitsPRO.com and ALM events.

Already have an account? Sign In Now
Join BenefitsPRO

Copyright © 2019 ALM Media Properties, LLC. All Rights Reserved.